Shenzhen started the construction of the first batch of "AI+" medical equipment professional parks. At the 2024 Shenzhen International High Performance Medical Equipment Exhibition and Innovative Medicine Exhibition held on December 12, a number of breakthrough cutting-edge technological achievements and innovative products were unveiled, and more than 200 famous medical equipment enterprises, scientific research institutions and medical institutions from home and abroad gathered to discuss cutting-edge technologies, explore innovative paths of medical equipment and help the high-quality development of the industry. In order to further seize the opportunity of artificial intelligence medical development, accelerate the digital transformation of Shenzhen's biomedical industry, gather a number of characteristic "AI+" medical equipment enterprises, and incubate a number of innovative medical equipment projects, Shenzhen started to build "AI+" medical equipment professional parks in key areas of industrial development. At this exhibition, the construction of the first batch of Shenzhen "AI+" pharmaceutical machinery professional parks, such as Baolong Biomedical Innovation and Development Pilot Zone, Nanshan Zhicheng, Hetao AI+ Biological Professional Park and Yinxing Science and Technology Park, was officially launched. Next, Shenzhen will vigorously improve the development and incubation of new quality productivity in the field of medical equipment, work together to shape the deep integration ecological pattern of "artificial intelligence+medical equipment", and accelerate the development and growth of "AI+" medical equipment industry.Klarna, a Swedish payment company, said that it stopped recruiting hundreds of employees because of AI during the year. Sebastian Siemiatkowski, CEO of Klarna, a Swedish payment company planning to go public in the US, said that the company stopped recruiting a year ago, mainly because it invested in artificial intelligence (AI), which can replace the work of hundreds of employees in the company. According to Siemiatkowski, the number of employees decreased by 22% to 3,500 within one year, mainly due to brain drain. He pointed out that at present, about 200 employees in the company use artificial intelligence for their core work, and will improve the efficiency of artificial intelligence by accelerating the salary growth of employees.Affected by martial law, the support rate of South Korean President Yin Xiyue fell to a record 11%.
Southern Power Grid: In November, the installed capacity of industrial and commercial distributed photovoltaic projects was newly put into operation, with more than 500 MW. Southern Power Grid (003035) said at the institutional investor strategy meeting on December 12 that in 2024, the company will continue to give full play to the advantages of distributed photovoltaic energy-saving track, focusing on key industries with good industry prospects, strong sustainable operation ability and large electricity consumption, and increase development efforts. According to preliminary statistics, from January to November 2024, the installed capacity of industrial and commercial distributed photovoltaic projects was newly put into operation with more than 500 MW.Pacific Securities: The reversal of photovoltaic industry is about to focus on three directions. The Pacific Securities Research Report pointed out that with the continuous breakthrough of new markets and technologies, the new cycle of photovoltaic parity is accelerating, and the reversal of photovoltaic industry is about to begin. It is suggested to focus on three directions: 1) The new cycle of supply and demand is expected to start in 2025, the industry quotation and profit are expected to be restored, and the leading advantages will be gradually highlighted. In 2025, it is expected to usher in a new round of growth, including Longji Green Energy and Jingke Energy. 2) New technology fields with large cost reduction space and continuous technology iteration, such as GCL Technology and Perovskite, are expected to fully benefit; 3) The advantages of supporting facilities and leading enterprises are prominent, and emerging markets are expected to promote the rapid improvement of shipments and profits, and the advantages of leading enterprises will be further enhanced, and enterprises such as Sunshine Power and Foster are expected to fully benefit.List of stock repurchases of Hong Kong stocks: 43 stocks were repurchased by the company. On December 12, a total of 43 Hong Kong stocks were repurchased by the company, and the repurchase amount of 8 stocks exceeded HK$ 10 million. Among them, Tencent Holdings, AIA and Samsonite have the largest repurchase amounts, with the company repurchasing HK$ 704 million, HK$ 61,711,300 and HK$ 34,247,500 respectively. As of December 12, 274 Hong Kong stocks have been repurchased by the company this year, and the cumulative repurchase amount of 62 stocks during the year exceeded HK$ 100 million. Among them, Tencent Holdings, HSBC Holdings and AIA have the largest cumulative repurchase amount during the year, with the company repurchasing HK$ 104.602 billion, HK$ 40.706 billion and HK$ 31.059 billion respectively.
Guojin Securities: The warm wind of medical policy comes first, then the progress of innovation going out to sea, and then the opportunity of performance reversal. Guojin Securities Research Report said that the core investment opportunities in the pharmaceutical sector in 25 years will revolve around three logics: 1) innovation going out to sea; 2) demand recovery; 3) Policy expectation reversal. At present, the policy warm wind comes first (the medical track policy continues to warm up, and the overall industry expectation is expected to be optimistic); Then, R&D and innovation will go to sea (innovative drug track will continue to make progress, and it will still be the hottest track in the pharmaceutical sector in 2025, especially it is recommended to pay attention to the clinical data reading and commercialization progress of the first-line target, as well as the fluctuation opportunity of the expected difference of the second-line innovative drugs), and then the performance growth rate is expected to bottom out in the first half of 2025 (but it will take time for this improvement in performance growth rate to come. Considering the current industry communication and historical base, it is expected that 4Q24 and 1Q25 should still be cautiously optimistic.)Maotai Group had an exchange discussion with Huawei. Kweichow Moutai official news on December 13th. On December 12th, Zhang Pingan, managing director of Huawei Technologies Co., Ltd. and CEO of Huawei Cloud, visited Maotai and held an exchange discussion with Zhang Deqin, Party Secretary and Chairman of Maotai Group.The Japanese side hyped China's threat to return to the old road of military expansion. Recently, Japanese Prime Minister Shi Pomao delivered a policy address saying that Chinese aircraft carriers sailed in the waters close to Japan's territorial waters, and carrier-based aircraft conducted thousands of take-off and landing trainings in the Pacific Ocean; Based on the national security strategy, Japan will greatly strengthen its defense forces. In this regard, Senior Colonel Wu Qian, director of the Information Bureau of the Ministry of National Defense and spokesman of the Ministry of National Defense, said that the Japanese side's hype about the so-called "China military threat" was just to cover up its usual trick of getting rid of the shackles of the peaceful constitution and taking the old road of military expansion again. As a matter of fact, the diplomatic and defense departments of China and Japan have been maintaining communication on air and sea security issues. There is absolutely no need for the Japanese side to be jittery and nervous. (CCTV)
Strategy guide
Strategy guide
12-14
Strategy guide
12-14